Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 5,918
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
Charlotte Bednarski Marie
ID: UNCST-2024-R003417
Transnational networks of care: international NGO management in Iganga, Uganda
REFNo: SS3628ES

PhD pre-dissertation research
USA 2025-02-20 18:29:52 2028-02-20 Social Science and Humanities Non-Clinical Trial Degree Award
KOBUSIINGYE FLORAH
ID: UNCST-2024-R001996
A MOBILE TEACHING-LEARNING FRAMEWORK FOR BRIDGING THE AGRICULTURAL EXTENSION GAP IN RESOURCE CONSTRAINED AREAS. A CASE STUDY OF KIGEZI SUB-REGION
REFNo: SIR464ES

Main Objective -To produce a comprehensive teaching-learning framework aimed at reducing the agricultural extension gap in the Kigezi region.

specific objectives
1. To evaluate current agricultural extension frameworks, identifying their strengths and weaknesses.
2. To design a mobile application framework that facilitates access to information, skills, and technology for farmers, extension officers, and other value chain actors.
3. To assess the feasibility and acceptability of the developed mobile agricultural extension application among farmers, extension officers, and other value chain actors.
Uganda 2025-02-20 18:27:15 2028-02-20 Engineering and Technology Non-Clinical Trial Degree Award
LOIS BAYIGGA
ID: UNCST-2024-R004310
PRE-CLINICAL TESTING OF FORWARD-ORIENTED GLOBIN-EXPRESSING LENTIVIRAL VECTOR
REFNo: HS5513ES

e) To determine the efficiency of magnetically assisted transduction in gene modified CD34+ cells, isolated from individuals with sickle cell disease or trait, using flow cytometry and real-time polymerase chain reaction (RT-PCR),d) To compare the efficiency of standard transduction to magnetically assisted transduction in CD34+ cells, isolated from individuals with sickle cell disease or trait, using a forward-oriented globin-expressing lentiviral vector using flow cytometry and real-time polymerase chain reaction (RT-PCR),c) To determine the presence of HbS mutation in the CD34 negative cells isolated from cord blood and red blood cell exchange products using hemoglobin electrophoresis.,b) To determine the yield, purity, and viability of CD34+ cells isolated from cord blood and red blood cell exchange products using multicolor flow cytometry ,a) To isolate hematopoietic stem and progenitor cells (CD34+) from cord blood and red blood cell exchange products using immunomagnetic-based method,To determine the efficacy of the forward-oriented globin-expressing lentiviral vector in HSPCs isolated from individuals with sickle cell disease or trait in Uganda,
Uganda 2025-02-20 18:26:20 2028-02-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Stella Muyanja Zawedde
ID: UNCST-2021-R014037
Effect of non-communicable disease multimorbidity on TB treatment outcomes amogn TBHIV co-infected patients in Uganda
REFNo: HS5506ES

a) To determine the prevalence of, and factors associated with multimorbidity among people with TB and HIV
b) To determine the effect of NCD Multimorbidity on TB treatment outcomes among persons co-infected with HIV.

Uganda 2025-02-20 17:58:06 2028-02-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Brenda Okech Apio
ID: UNCST-2022-R011031
Epidemiology of Malaria Infection in Sub-Saharan African Countries
REFNo: HS5543ES

Primary Objective
1.To estimate the site-specific IR of
P. falciparum infection by rapid
diagnostic test (RDT) testing,
overall and by age group (5-11
years, 12-17 years, 18-60 years)
during the active detection of
infection period.
Secondary objectives
1.To evaluate the agreement
between RDT and thick blood
smear (TBS), and to evaluate the
sensitivity and specificity of RDT
and TBS using quantitative
polymerase chain reaction (qPCR)
as the gold standard for the
identification of P. falciparum
infection, at baseline and at two
and six months after enrolment.
2.To estimate the site-specific IR of
P. falciparum infections detected
by both active and passive
surveillance over the complete follow-up period (0-6 months),
overall and by age group (5-11
years, 12-17 years, 18-60 years).
Uganda 2025-02-20 17:55:11 2028-02-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."